Skip to content
TrialScanner

NCT05052554

Study With QR-504a to Evaluate Safety, Tolerability & Corneal Endothelium Molecular Biomarker(s) in Subjects With FECD3

Phase 1WithdrawnPRQRLead

Registry record

Lead sponsor
ProQR Therapeutics
Conditions
Fuchs Endothelial Corneal Dystrophy; FECD3; Corneal Diseases; LRS; Descemet's Membrane Disorder
Primary completion
Apr 12, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05052554 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.